Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

The National Infusion Center Association (NICA) Is Now a Trade Association; New Public Charity Dedicated to Patient Empowerment, Education, and Advocacy is Born


Since 2010, the National Infusion Center Association (NICA) has been the leading voice for access to infusion therapies. Today marks a historic day for provider-administered medication stakeholders as NICA is now a trade association that will serve as the national voice for non-hospital, community-based infusion providers that constitute a safe, more efficient, and more cost-effective alternative to hospital care settings.

The trade group’s efforts will focus on delivery channel sustainability and expansion, buy-and-bill protection, maintaining net positive reimbursement, improving treatment adherence, and promoting patient safety and care quality.

NICA supports policies that improve drug affordability for beneficiaries, increase price transparency, reduce disparities in quality of care and safety across care settings, and enable care delivery in the highest-quality, lowest-cost care setting.

Ultimately, NICA’s goal is to optimize health outcomes and quality of life among the nation’s most vulnerable patient populations while reducing patient out-of-pocket costs, reducing waste, and bringing tremendous value to patients, Medicare, and commercial insurers.

“Patients requiring medical benefits drugs rely on affordable access to care to optimize their health, maximize their quality of life, and minimize the physical, emotional, and economic burdens of disease. Our nation’s community-based infusion centers represent a critical delivery channel in which patients can receive the high-quality care they need in a safe environment at a fraction of the cost of hospitals,” says President and CEO, Brian Nyquist, on behalf of the organization.

NICA’s public charity has become the Infusion Access Foundation (IAF), an inclusive community dedicated to patient empowerment, education, and advocacy. IAF will work tirelessly to ensure that patients have access to provider-administered therapies for any and all complex illnesses by creating an inclusive community through which patients can share their stories, educate and empower themselves and others, connect with other patients, and amplify the collective patient voice to collaboratively drive change. Together, for treatment.

Both organizations will collaborate to tackle access challenges through targeted approaches that best fit their stakeholder needs.

To learn more about the National Infusion Center Association, visit infusioncenter.org. To learn more about the Infusion Access Foundation, visit patientaccess.org. For media inquiries, contact Cristina Threlkeld (cristina.threlkeld@infusioncenter.org).

Share article on social media or email:

QSimulate triages diverse drugs against COVID-19 target using novel highly parallel quantum mechanics


In a new publication, scientists at start-up QSimulate describe the application of a new and novel implementation of quantum mechanics (QM) to the question of how well various diverse drugs bind to SARS-CoV-2 Mpro, a protein required for the replication of COVID-19. The diversity in structure and formal charge of this set is large, rendering accurate scoring by traditional methods difficult or impossible. However, QSimulate has demonstrated that QM with high accuracy can successfully rank binding strength for this challenging set. The results suggest a broader path forward for the integration of QM in drug discovery. These calculations were made possible by a combination of A) new QM architecture that allows the calculations to be run in parallel on thousands of processor cores and utilizing an unprecedented amount of distributed memory and B) access to the necessary computational resources through Amazon Web Services (AWS). Combined, these factors have allowed QSimulate to accelerate the time required to process these calculations from weeks to hours.

In the study, the authors apply the QM method known as Density Functional Theory to score and rank the ability of 15 diverse drugs to bind the Mpro protein. The 15 drugs have all previously been experimentally confirmed to bind to Mpro.

Dr. David A. Pearlman, the lead author on the study and Vice President of Product at QSimulate notes that “The results we have obtained are exciting. Accurately rank-ordering the binding for a set of very different drugs such as this one using classical approaches has traditionally been a huge challenge. Not only do our results provide first-time validation of high-accuracy quantum mechanics in the context of drug triage, but they also demonstrate that we can use this approach to further our search for COVID-19 drugs. More broadly, it suggests a role for QM in hit-to-lead drug discovery triage very poorly served by existing computational methods.”

Adds Professor Garnet Chan of Caltech, co-founder and Chief Scientific Advisor to QSimulate, “We have long known how to solve the equations of quantum mechanics to make them applicable to real-world systems. However, it wasn’t until we brought new algorithms and the power of cloud computing to bear that we could hope to run these calculations quickly enough to make them useful.” Scientists at QSimulate figured out how to parallelize QM across a distributed system like AWS. This unlocks the power of QM for drug discovery. Chan continues, “Without our new approach, these calculations would have taken weeks to complete. Now we can finish them in hours.”

Dr. Toru Shiozaki, CEO and co-founder of QSimulate summarizes, “10 years ago, the best we could do with an accurate quantum simulation was to look at very small model systems with little relevance to real-world pharmaceutical problems. The fact that we are now at a place where QM has demonstrable relevance to drug discovery, AI, and more is fantastically satisfying.”

The results are described in the preprint titled “Quantum Simulations of SARS-CoV-2 Main Protease Mpro Enable Accurate Scoring of Diverse Ligands” (https://arxiv.org/abs/2010.07883) which is authored by Yuhang Wang, Sruthi Murlidaran, and David A. Pearlman, all of QSimulate. These calculations were made possible by donated computing credits provided by AWS.

Share article on social media or email:

National Infusion Center Association (NICA) Partners With Top D.C. Government Relations Firm in First Action As a Trade Association


The National Infusion Center Association (NICA) has become a trade association dedicated to advancing the office-based delivery channel for provider-administered medications. NICA’s first priority as a trade association was to engage Hart Health Strategies, a D.C.-based government relations firm, to strengthen the voice of non-hospital, community-based infusion providers in high-level national policy discussions with decision makers.

Hart Health Strategies (HHS) is a bi-partisan consulting and lobbying firm specializing in legislative and regulatory health care issues. The HHS team has extensive experience and expertise working on coalition building, educating key members of Congress and administration officials on important health issues, advocating for health-related federal funding, and conducting policy research. The HHS team bolsters NICA’s bi-partisan legislative expertise and multi-talented backgrounds in health-related fields, including nursing, epidemiology, and health information management. As a firm focused exclusively on healthcare, we are excited for them to complement our deep, substantive expertise on medical benefit and healthcare policy issues, including Medicare payment, quality reporting, the pharmaceutical supply chain, and coverage issues in building a strong infusion provider voice and presence in D.C.

President and founder of Hart Health Strategies, Vicki Hart, has personal relationships with numerous members of Congress on both sides of the aisle, and the entire HHS team has longstanding relationships with staff representing both parties in both chambers.. Previously, the firm’s staff worked for the United States Senate within leadership, in personal offices, and at the committee level. In the House of Representatives, staff worked at the committee level and for senior members of all three key health care committees.

Through this new strategic engagement, NICA is excited to continue championing for the medical benefit drug delivery channel and the value it brings to optimizing health outcomes, maximizing quality of life, and minimizing the physical, emotional, and financial burdens of complex, chronic disease for our nation’s most vulnerable citizens.

The National Infusion Center Association (NICA) is a nonprofit organization with the mission to preserve and advance the trade of furnishing provider-administered medications in non-hospital, community-based care settings. NICA’s efforts are focused on addressing and overcoming challenges and threats to the sustainability of the most affordable care setting for provider-administered medications.

Share article on social media or email:

The Infusion Access Foundation’s Mission is Rooted in Raising Patient Voices


The Infusion Access Foundation (IAF) has been created to serve as an inclusive community dedicated to patient empowerment, education, and advocacy. As a non-profit advocacy group and public charity dedicated to ensuring that patients have access to provider-administered therapies for any and all complex diseases, IAF believes that all patients deserve treatment that works for them.

To truly understand the inception of the Infusion Access Foundation, it’s necessary to start 10 years ago with the National Infusion Center Association, or NICA. As a non-profit dedicated to improving patients’ access to provider-administered medications, NICA’s team of experts and advocates worked together to support more accessible, efficient, and cost-effective alternatives to hospitals for their infusion treatments. Amidst the immense challenge and strains brought by COVID-19 this year, it became apparent to the NICA team that the future for patients’ access to care would be determined by two factors (1) patients needed a dedicated support community through which they could share their stories, educate and empower themselves and others, connect with other patients, and amplify the collective voice of patients to collaboratively drive change; (2) infusion providers needed a dedicated organization to champion their trade and professional interests so they could continue providing high-quality care to their patients in a safe environment. Thus, the Infusion Access Foundation was born as a patient-focused public charity, and NICA evolved into a trade association focused on the advancement of furnishing provider-administered medications in non-hospital, community-based care settings.

Where NICA will work to support the viability and sustainability of the non-hospital, community-based provider-administered medication delivery channel, IAF will serve as a supportive and inclusive community for the patients receiving these life-changing medications as they seek understanding, empowerment, and unwavering support throughout their disease management journey.

The Infusion Access Foundation believes that every patient is unique and that their experience matters. That is why IAF created a community devoted to bringing patients together, hearing and sharing their stories, and amplifying their voices to drive change. Together, for treatment.

The Infusion Access Foundation works tirelessly to ensure people have access to provider-administered therapies for any and all complex illnesses. Through advocacy initiatives, grassroots campaigns and community forums, we help patients stand against adversity and raise their voices to the world. Visit PatientAccess.org to join the fight today.

Share article on social media or email:

Westwind Integrated Health Provides Tele-Medicine and Tele-Dentistry in Phoenix, AZ During COVID-19


The Dentists and Primary Care Doctors at Westwind Integrated Health, Serving Phoenix, AZ

The Dentists and Primary Care Doctors at Westwind Integrated Health Serve Phoenix, AZ Virtually

Care that does not require in-person treatment can be completed entirely by phone to ensure the highest level of safety for patients and staff.

The team of Phoenix, AZ dentists and primary care doctors at Westwind Integrated Health (WIH) welcomes new and existing patients for tele-medicine and tele-dentistry to help limit the spread of COVID-19. Patients experiencing symptoms or interested in discussing elective treatment can schedule a confidential phone consultation as an alternative to an in-person appointment by calling one of the nine practice locations around the greater Phoenix, AZ area. The medical-dental team is dedicated to providing the same high-quality and personalized service patients can expect with in-person care.

Amid the COVID-19 pandemic, patients can continue to receive the medical and dental care they need from an experienced team of primary care doctors, dentists, and dental specialists at Westwind Integrated Health, all while avoiding in-person contact unless necessary. Patients will still experience personalized and compassionate care from the team through a phone consultation where they can discuss their symptoms, ask questions, and learn more about treatment options.

Patients can address concerns and seek consultations related to primary medical care for women, men, and children, as well as dental care, including general dentistry, orthodontics, endodontics, periodontics, and oral surgery. Care that does not require in-person treatment can be completed entirely by phone to ensure the highest level of safety for patients and staff. If an in-office consultation or treatment is necessary to restore physical and dental health, the WIH team adheres to all advanced safety and sanitization measures based on current Centers for Disease Control and Prevention (CDC) guidelines for their staff, equipment, and facilities.

The WIH team has been actively involved in the community during the COVID-19 pandemic, having treated over 1,000 emergency patients since the beginning of the pandemic. The dedicated team works 12 hours a day, six days a week to ensure the patients of their community are in great physical and oral health and have a healthy immune system to help fight infection, disease, and dangerous viruses. Unique to WIH, this whole-body approach coupled with a superior level of compassion and personalization sets the team apart, especially as the only dental-medical providers in the state of Arizona.

New and existing patients concerned about limiting the spread of COVID-19 can now reserve their confidential tele-medicine or tele-dentistry consultation with WIH by visiting http://www.westwindintegratedhealth.com or calling 602-457-8024. The primary care doctors and dentists in the Phoenix, AZ and surrounding practice locations welcome patients to contact them if they have dental and/or medical symptoms or would like to discuss treatment options.

About the Practice

Westwind Integrated Health offers dental and medical care from nine locations in the Glendale and Phoenix, AZ areas. As the only private practice in Arizona and one of only a few practices in the country to combine dental and medical care, this team is innovating health care by offering truly comprehensive care with a whole-body approach. Comprised of a multi-disciplinary team of medical doctors and dental clinicians, Westwind Integrated Health offers specialized general dentistry, orthodontics, endodontics, periodontics, oral and maxillofacial surgery. Plus, under the same roof, patients can receive physicals and wellness exams, vision and hearing screenings, vaccinations, nutritional counseling, and minor injury treatment. The family of practices focuses on building genuine patient relationships, comprehensive and state-of-the-art treatment, and improving the long-term health and wellbeing of their patients. To learn more about the multi-specialty team, visit http://www.westwindintegratedhealth.com or call 602-457-8024 to schedule an integrated health consultation.

Share article on social media or email:

HealthyChildren.org Celebrates Halloween with Spooktacular Sweepstakes Event


News Image

HealthyChildren.org Spooktacular Sweepstakes Event

HealthyChildren.org, the official American Academy of Pediatrics (AAP) website for parents, celebrates Halloween by giving away ten $200 Visa gift cards in the site’s Spooktacular Sweepstakes event.

Registered users of HealthyChildren.org may enter once each day during the event which runs October 22 through October 31, 2020. Winners will be drawn daily and announced on Facebook as they are confirmed. View the full contest rules.

About HealthyChildren.org

The only parenting website backed by 67,000 AAP member pediatricians, HealthyChildren.org offers trustworthy, up-to-the-minute health advice and guidance for parents and caregivers, along with interactive tools and personalized content. Registered users enjoy a customized home page featuring articles appropriate for their children by age, as well as a free monthly e-newsletter.

The site also offers a Find a Pediatrician service, an Ask the Pediatrician tool, a KidsDoc Symptom Checker, and more than 5,000 articles in English and Spanish.

Share article on social media or email:

Dr. Elizabeth Kilpatrick-Fox of Swedesboro, New Jersey Is Now Offering Cosmetic Dentures


Dr. Elizabeth Kilpatrick-Fox

Dr. Elizabeth Kilpatrick-Fox

Elizabeth Kilpatrick-Fox, DMD of Swedesboro, New Jersey has been reviewed and approved by NJ Top Dentists for 2020. Dr. Kilpatrick-Fox has dedicated her life and career to ensuring the oral health of her patients. She is committed to providing each patient with a beautiful smile.

Dr. Fox has utilized her many years of Implant and Cosmetic Dentistry experience to offer an upscale Cosmetic Denture at her office.

According to Dr. Fox, “Cosmetic dentures typically look more like real teeth than less expensive versions that people are often given. Now with an option of Cosmetic Dentures, a patient can see they fit naturally, allowing them to speak more clearly and enjoy eating once again.”

Dr. Fox also now offers a more advanced version of these dentures called the Hybrid Cosmetic Denture. These combine some of the best features of dentures with the stability of implants.

Having worked in the field of Implant Dentistry for many years, Dr. Fox says she often found the most successful cases happen when she discusses multiple solutions for the patient’s problem. This was true whether the patient’s problem was with dentures, implants, or any other dental issue.

A few key benefits of the Hybrid Cosmetic Dentures that Dr. Fox offers include:

  • Renews patient’s youthful appearance and new found confidence
  • Allows patients to enjoy a wider range of foods
  • Long lasting results
  • Easy maintenance
  • Reduced costs when compared to single replacement implants
  • Can eliminate the need for bone grafting

Currently, Dr. Fox offers the following denture related services:

  • Full and partial dentures
  • All treatments are handled in her state-of-the-art office
  • Denture repairs and adjustments
  • Denture relines

To learn more about Dr. Elizabeth Kilpatrick-Fox and her full service dental practice, please visit: https://njtopdocs.com/nj-dentists/drelizabethkilpatrickfox/

—

About Us

NJ Top Dentists is a division of NJ Top Docs. NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



Rigaku Presents Latest Analytical Technology at analytica virtual


Rigaku MiniFlex XRD

6th Generation Rigaku MiniFlex benchtop X-ray Diffraction (XRD) spectrometer

Rigaku provides the world’s most complete line of X-ray analytical instruments and components and is showcasing its latest X-ray analytical instrumentation at three virtual booths.

Rigaku Corporation is pleased to announce its participation in the 27th international Trade Fair for Laboratory Technology, Analysis and Biotechnology via analytica virtual, highlighting the latest developments, modern analytical instrumentation and techniques.

In response to the recent coronavirus outbreak and cancellation of live trade fairs globally, analytica will likewise not take place as a live trade fair this year, rather as a virtual, online event. The analytica virtual tradeshow will take place from October 19 to 23, 2020. The online event will be accessible around the clock, with over 1,000 listed companies and around 30,000 visitors sharing expertise in biotechnology, quality inspection, laboratory techniques, clinical diagnostics and life sciences.

Rigaku provides the world’s most complete line of X-ray analytical instruments and components, including benchtop X-ray diffraction (XRD) and X-ray fluorescence (XRF) systems, handheld analyzers, X-ray optics and detectors, and is showcasing its latest X-ray analytical instrumentation at three virtual booths.

The Rigaku Europe SE virtual booth features XRD and wavelength dispersive X-ray fluorescence (WDXRF) systems. Among the instruments featured is the sixth generation Rigaku MiniFlex benchtop X-ray diffraction diffractometer. It is a multipurpose benchtop XRD system able to determine crystalline phase identification and phase quantification and perform qualitative and quantitative analysis of polycrystalline materials.

The Rigaku SmartLab high-resolution X-ray diffractometer is an automated multipurpose XRD system features guidance software for powder diffraction, thin film metrology, SAXS, in-plane scattering and operando measurements.

Employed for both R&D and quality assurance (QA) functions, WDXRF systems from Rigaku are routinely used to analyze products from cement to plastics and from metals to food to semiconductor wafers.

Featured systems include the Rigaku Supermini200 analyzer. It is the world’s only high-power (200 W) benchtop sequential wavelength dispersive X-ray fluorescence spectrometer for elemental analysis of oxygen (O) through uranium (U) in solids, liquids and powders. It delivers both high resolution and lower limits of detection (LLD), along with low cost-of-ownership.

The new high power Rigaku ZSX Primus IV𝒾 sequential WDXRF spectrometer features new ZSX Guidance expert system software, improved performance and a smaller footprint. It is especially suited for analysis of liquids, alloys, and plated metals.

The Applied Rigaku Technologies, Inc. (ART) booth features Energy Dispersive X-ray Fluorescence (EDXRF) systems for elemental analysis, including the Rigaku NEX DE VS variable spot size spectrometer. The unit delivers wide elemental coverage with easy-to-learn Windows®-based QuantEZ software.

The Rigaku line of process analyzers offer real-time, on-line process elemental analysis of aluminum (Al) through uranium (U) by EDXRF, coatings analysis for web or coil applications, and total sulfur measurement in petroleum and crude by X-ray transmission.

The Rigaku portfolio of handheld spectroscopic analyzers will be highlighted at the Rigaku Analytical Devices booth. These instruments are designed to perform material identification for various applications including safety and security, pharmaceutical manufacturing, and metal alloy verification, while being rugged and robust enough to handle the most hostile of environments.

Handheld analyzers from Rigaku utilize the 1064nm Raman advantage for more comprehensive analysis and fast results – in a matter of seconds. The Rigaku Progeny handheld analyzer is used by pharmaceutical manufacturers for raw material identification and finished product authentication. The Progeny ResQ Raman analyzer is designed to provide emergency responders, law enforcement agencies and the military with a comprehensive tool for rapid chemical threat identification, while the Rigaku ResQ CQL delivers identification and detection of chemical threats and narcotics in a new tactical design with improved ergonomics.

For rapid, precise metal alloy verification, the handheld Rigaku KT-100S analyzer utilizes laser induced breakdown spectroscopy (LIBS) to easily perform fast and safe identification of the most difficult alloy grades.

Rigaku supplies solutions for pharmaceutical, mining, cement, safety and security, scrap metal, quality and process control industries among others and is pleased to have this opportunity to leverage its understanding of X-ray and complementary technologies to promote partnerships, dialog, and innovation within the global scientific and industrial communities.

More information is available at http://www.rigaku.com/showcase/analytica2020.

About Rigaku

Since its inception in Japan in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on general-purpose analytical instrumentation and the life sciences. With hundreds of major innovations to their credit, Rigaku companies are world leaders in X-ray spectrometry, diffraction, and optics, as well as small molecule and protein crystallography and semiconductor metrology. Today, Rigaku employs over 1,400 people in the manufacturing and support of its analytical equipment, which is used in more than 90 countries around the world supporting research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial communities.

For further information, contact:

Michael Nelson

Rigaku Global Marketing Group

tel: +1. 512-225-1796

michael.nelson@rigaku.com

Share article on social media or email:

Huntington Plastic Surgery Institute Opens its Doors in Pasadena


Dr. Sepideh Saber and Dr. Mort Rizvi.

[The Huntington Plastic Surgery Institute] will be offering the skills of some of Southern California’s finest board certified plastic surgeons in a welcoming and attractive setting.

Huntington Plastic Surgery Institute, a medical group offering a wide variety of plastic surgeries and cosmetic procedures, is now open to patients of all ages and genders at its location in the heart of Pasadena. The clinic says that it will be offering the skills of some of Southern California’s finest board certified plastic surgeons in a welcoming and attractive setting. The chief plastic surgeons at the institute, Huntington says, will be Dr. Sepideh Saber and Dr. Mort Rizvi.

The medical center says that Dr. Saber has achieved recognition for an approach that blends the abilities of an expert plastic surgeon with an unusual level of sensitivity. Huntington says that, as a woman and a mother, Dr.Saber brings a unique perspective to a male-dominated field. Dr. Saber herself adds that, while many women might feel more comfortable with a woman plastic surgeon performing mommy makeovers and other female-centric procedures, she has worked very productively with people of all genders. She adds that even fairly traditional males often feel they can benefit from a more empathetic approach based on careful listening to patients.

Moving on, the Huntington Plastic Surgery Institute says that Dr. Mort Rizvi is arguably one of the most versatile physicians working in California. Board certified in both plastic surgery and hand surgery, Dr. Rizvi has also worked as a craniofacial and reconstructive surgeon. He is also a widely noted expert in microsurgery, says the institute. After beginning his medical training in Maryland and then completing his residency at Houston Methodist Hospital, Huntington says that Dr. Rizvi has worked with some of the most prestigious names in Southern California medicine, including Los Angeles County + USC Medical Center as well as Children’s Hospital.

The institute adds that it offers all of the most commonly obtained procedures including rhinoplasty (nose jobs), breast and buttock augmentation, liposuction, tummy tucks, and more. The medical center adds that it also provides such widely obtained facial rejuvenation procedures as surgical facelifts (rhytidectomy) and eyelid lifts (blepharoplasty). Also on offer are nonsurgical facial rejuvenation including Botox and fillers, says the institute. It says that, while many practitioners without MDs are legally allowed to provide injectables, there are important benefits in terms of safety and outcomes when these products are provided by a board certified plastic surgeon.

The Huntington Plastic Surgery Institute is located on the second floor of 3900 Congress Street approximately one mile from the 134 Freeway’s Orange Grove exit in Pasadena. Readers interested in further information can call the office at 1-626-792-4385 or visit its website at https://huntingtonplasticsurgeryinstitute.com/.

Share article on social media or email:

Dr. Christina Cone Honored With The Mary Pazdur Award for Excellence in Advanced Practice in Oncology by APSHO


Christina is a remarkable clinician, leader, and educator who impacts the lives of her patients.

The Advanced Practitioner Society for Hematology and Oncology (APSHO) presented the third annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology to Christina Cone, DNP, APRN, ANP-BC, AOCNP®, of Duke Cancer Institute, at the JADPRO Live Virtual conference, an annual educational conference for oncology advanced practitioners.

The annual award, created in honor of Mary Pazdur, RN, MSN, is given to an advanced practitioner APSHO member who consistently demonstrates exemplary leadership and outstanding contributions to clinical practice, research, and education in the oncology/hematology field.

Christina Cone, DNP, APRN, ANP-BC, AOCNP®, is a board-certified adult nurse practitioner and serves as the Administrative Director of The Preston Robert Tisch Brain Tumor Center (PRTBTC) at the Duke Cancer Institute, one of the largest brain tumor centers in the world. She also serves as the Administrative Director for the Duke Center for Brain and Spine Metastasis, which focuses on the treatment of solid tumor brain and spine metastases. She was previously the Advanced Practice Provider Team Lead at the PRTBTC, where she had been a seasoned nurse practitioner since 2010.

“Christina is a brilliant and inspirational leader, and it is one of the professional pleasures of my life to be able to work so closely with her on a daily basis in our extraordinarily busy oncology program,” said Henry S. Friedman, MD, Division Chief in the Department of Neurosurgery and Deputy Director of the PRTBTC at Duke. “I truly believe Christina is a remarkable clinician, leader, and educator who impacts the lives of her patients as dramatically as she does the lives of the health-care professionals in the PRTBTC and the Center for Brain and Spine Metastasis.”

Dr. Cone obtained a Doctorate in Nursing Practice from East Carolina University in 2016 and a Master of Science in Nursing in the Adult Nurse Practitioner (ANP) program with a specialty in oncology from the Duke University School of Nursing in 2004. She has been practicing advanced oncology nursing as a board-certified adult nurse practitioner for 15 years.

“Dr. Cone is an advocate for interdisciplinary advanced practice providers (APPs) to practice to the extent of their licensure and education,” commented Mary Lou Affronti, DNP, RN, MHSc, ANP, Brain Tumor Center Adult Clinical Director, Brain Tumor Center Nurse Practitioner/Primary Investigator, and Associate Professor at the Duke School of Nursing. “Under her leadership, she has effectively set up independent APP-led clinics where nurse practitioners, physician assistants, and clinical pharmacists can autonomously practice to improve patient care and access.”

Past recipients of the award include Jody Pelusi, PhD, FNP, AOCNP®, of HonorHealth Research Institute in Scottsdale, Arizona, and Jeannine Brant, PhD, APRN, AOCN®, FAAN, of Billings Clinic in Billings, Montana.

APSHO is accepting nominations for the fourth annual Mary Pazdur Award for Excellence in Advanced Practice, which will be presented at the 2021 JADPRO Live conference. The winner will receive an honorarium and an all-expenses-paid trip to the 2021 conference, as well as recognition at the meeting and in the Journal of the Advanced Practitioner in Oncology.

To learn more about the Mary Pazdur Award, please visit marypazduraward.com.

About JADPRO Live

JADPRO Live is a medical conference inspired by the Journal of the Advanced Practitioner in Oncology. This year’s meeting takes place from October 15 through 23, with encore showings of select presentations from October 26 through November 6.

About APSHO

The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society for advanced practitioners—nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other oncology health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.

Share article on social media or email: